Anne Li 1/29/17
A study, partly funded by Worldwide Cancer Research, reveals for the first time that the protein CPEB4 can prevent fatty liver disease. The results were published today in Nature Cell Biology. A team co-led by two Worldwide Cancer Research scientists at the Institute for Research in Biomedicine (IRB Barcelona) and the IDIBAPS Biomedical Research Institute (part of the Hospital Clínic de Barcelona) has revealed the ability of the protein CPEB4 to prevent fatty liver disease. This condition generally leads to chronic inflammation (non-alcoholic steatohepatitis), which can trigger fibrosis, cirrhosis and ultimately liver cancer. This study, on the basic biology of the liver, paves the way to examine new therapeutic strategies to fight and prevent fatty liver disease.
See original article at: https://www.worldwidecancerresearch.org/news/researchers-discover-protein-protects-fatty-liver-common-liver-disease-western-countries/